The lymphomas that are the subject of the recent safety alert aren't the same as breast implant-associated anaplastic large cell lymphoma, which the FDA began describing as a potential risk more than a decade ago. News From the Food and Drug Administration Reports of squamous cell carcinomas and various lymphomas in scar tissue around breast implants spurred the FDA to issue a recent safety alert.